| Christine L Canterbury, MD | |
|
7121 Spid, Suite 302, Corpus Christi, TX 78412 | |
| (361) 851-5000 | |
| (361) 851-0590 |
| Full Name | Christine L Canterbury |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 7121 Spid, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104899152 | NPI | - | NPPES |
| 038389501 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | K4010 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Corpus Christi Medical Center,the | Corpus christi, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nueces County Women's Clinic, Pa | 0345206082 | 4 |
News Archive
The program helps reinforce the importance of health care for shelter residents and their children.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
New University of Birmingham research funded by the British Heart Foundation could improve treatments for a potentially deadly condition that affects tens of thousands of people in the UK each year.
› Verified 4 days ago
| Entity Name | Nueces County Women's Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669503009 PECOS PAC ID: 0345206082 Enrollment ID: O20041206000118 |
News Archive
The program helps reinforce the importance of health care for shelter residents and their children.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
New University of Birmingham research funded by the British Heart Foundation could improve treatments for a potentially deadly condition that affects tens of thousands of people in the UK each year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine L Canterbury, MD 7121 Spid, Suite 302, Corpus Christi, TX 78412 Ph: (361) 851-5000 | Christine L Canterbury, MD 7121 Spid, Suite 302, Corpus Christi, TX 78412 Ph: (361) 851-5000 |
News Archive
The program helps reinforce the importance of health care for shelter residents and their children.
Cell Therapeutics, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed, aggressive non-Hodgkin's lymphoma (NHL).
N30 Pharmaceuticals, Inc. announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial. N91115, a novel inhibitor of S-nitrosoglutathione reductase (GSNOR), is being developed for the treatment of cystic fibrosis (CF).
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
New University of Birmingham research funded by the British Heart Foundation could improve treatments for a potentially deadly condition that affects tens of thousands of people in the UK each year.
› Verified 4 days ago
Sultana Alamin Khimani, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 5920 Saratoga Blvd, Suite 570, Corpus Christi, TX 78414 Phone: 361-985-8100 Fax: 361-985-8131 | |
Danielle Alicia Inman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Dr. Jeffery Blaine Itkin, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5920 Saratoga Boulevard, Suite 540, Corpus Christi, TX 78414 Phone: 361-883-6030 Fax: 361-883-6442 | |
Mrs. Leighanne Glazener, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7121 S Padre Island Dr, Suite 302, Corpus Christi, TX 78412 Phone: 361-851-5000 Fax: 361-851-8053 | |
Juan A Villarreal, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13725 Northwest Blvd, Suite #110, Corpus Christi, TX 78410 Phone: 361-387-7177 Fax: 361-387-8355 | |
Romulo Corrada, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7121 S Spid Dr, Ste 200, Corpus Christi, TX 78412 Phone: 361-993-6000 Fax: 361-993-3676 |